EcoDrugPlus

Sphingosine Kinase 2-Like

Ensembl ID : ENSFHEG00000022750
Gene Symbol: LOC105928428
2 Cross references
201 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSFHEG00000002632
Gene Symbol: S1PR1
3 Cross references
193 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSFHEG00000015261
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSFHEG00000001611
Gene Symbol: LOC105917304
3 Cross references
211 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSFHEG00000005012
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSFHEG00000017024
Gene Symbol: LOC105916876
3 Cross references
194 Possible Orthologues:

Synaptic Vesicular Amine Transporter

Ensembl ID : ENSFHEG00000007857
Gene Symbol: LOC105920721
3 Cross references
216 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSFHEG00000023196
Gene Symbol: TACR1
4 Cross references
213 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSFHEG00000011002
Gene Symbol: TACR2
3 Cross references
197 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSFHEG00000022605
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSFHEG00000004784
Gene Symbol: TBXAS1
3 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSFHEG00000018414
Gene Symbol: TBXA2R
3 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).